Please use this identifier to cite or link to this item:
Type: Artigo de periódico
Title: Caffeic acid phenethyl ester reduces the activation of the nuclear factor kappa B pathway by high-fat diet-induced obesity in mice
Author: Neves Bezerra, Rosangela Maria
Veiga, Lucimara Fernanda
Caetano, Aline Camila
Rosalen, Pedro Luiz
Corezola Amaral, Maria Esmeria
Palanch, Adrianne Christine
de Alencar, Severino Matias
Abstract: Objective. The aim of this study was to investigate the effect of CAPE on the insulin signaling and inflammatory pathway in the liver of mice with high fat diet induced obesity. Material/Methods. Swiss mice were fed with standard chow or high-fat diet for 12-week. After the eighth week, animals in the HFD group with serum glucose levels higher than 200 mg/dL were divided into two groups, HFD and HFD receiving 30 mg/kg of CAPE for 4 weeks. After 12 weeks, the blood samples could be collected and liver tissue extracted for hormonal and biochemical measurements, and insulin signaling and inflammatory pathway analyzes. Results. The high-fat diet group exhibited more weight gain, glucose intolerance, and hepatic steatosis compared with standard diet group. The CAPE treatment showed improvement in glucose sensitivity characterized by an area under glucose curve similar to the control group in an oral glucose tolerance test Furthermore, CAPE treatment promoted amelioration in hepatic steatosis compared with the high-fat diet group. The increase in glucose sensitivity was associated with the improvement in insulin-stimulated phosphorylation of the insulin receptor substrate-2, followed by an increase in Akt phosphorylation. In addition, it was observed that CAPE reduced the induction of the inflammatory pathway, c-jun-N- terminal kinase, the nuclear factor kappa B, and cyclooxygenase-2 expression, respectively. Conclusions. Overall, these findings indicate that CAPE exhibited anti-inflammatory activity that partly restores normal metabolism, reduces the molecular changes observed in obesity and insulin resistance, and therefore has a potential as a therapeutic agent in obesity. (C) 2012 Elsevier Inc. All rights reserved.
Subject: Anti-inflammatory activity
Insulin resistance
c-jun N-terminal kinase
Insulin receptor substrate-2
Editor: W B Saunders Co-Elsevier Inc
Citation: Metabolism-Clinical and Experimental. W B Saunders Co-Elsevier Inc, v.61, n.11, p.1606-1614, 2012
Rights: fechado
Identifier DOI: 10.1016/j.metabol.2012.04.006
Date Issue: 2012
Appears in Collections:FCA - Artigos e Outros Documentos

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.